ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag spinal cord injury developmental biology disease medicine genetics genomics

The Future Looks Bright for Genetic Medicine
Ronald Crystal | Nov 21, 2004 | 5 min read
Today, gene therapy, genomics, and stem cell therapy are considered to be discrete fields of research.
Scientists Strike a Cord
Rabiya Tuma | Feb 9, 2003 | 6 min read
Courtesy of SR Eng  BABY STAINS: The head of a transgenic murine embryo in which a marker enzyme has been specifically expressed in the sensory neurons of the trigeminal and dorsal root ganglia. The marker allows staining of the projections of these neurons into, among other areas, the hindbrain and spinal cord. (S.R. Eng et al., "Defects in sensory axon growth precede neuronal death in Brn3a-deficient mice," J Neurosci, 21:541-9, 2001.) Somewhere in the 200 million bases of the human ge
Stem Cells Made Waves in Biology and Medicine
Karen Zusi | Oct 1, 2016 | 6 min read
Since their introduction to the lab, pluripotent stem cells have gone from research tool to therapeutic, but the journey has been rocky.
Whither Cell Biology?
Richard Hynes | Dec 10, 2000 | 6 min read
Illustration: A. Canamucio Cell biology has become the third overlapping core discipline of modern biology, along with biochemistry and genetics. Progress over the century--since E.B. Wilson's classic book1 elegantly framed many of the questions of cell biology--has relied on advances in technology and yielded fascinating insights into the ways that cells work. We now have an unprecedented understanding of the structure, organization, and functions of cells. As the number of completed ge
How Groups of Cells Cooperate to Build Organs and Organisms
Michael Levin | Sep 1, 2020 | 10+ min read
Understanding biology’s software—the rules that enable great plasticity in how cell collectives generate reliable anatomies—is key to advancing tissue engineering and regenerative medicine.
Preimplantation Genetic Diagnosis: The Next Big Thing?
Ricki Lewis | Nov 12, 2000 | 9 min read
Courtesy of David Hill, ART Reproductive Center Inc.Two separated blastomeres subjected to FISH analysis to check the chromosomes. In early October, preimplantation genetic diagnosis (PGD) made headlines when a Colorado couple used assisted reproductive technology (ART) to have a baby named Adam, whose umbilical cord stem cells could cure his six-year-old sister Molly's Fanconi anemia.1 When Adam Nash was a ball of blastomere cells, researchers at the Reproductive Genetics Institute at Illinois
Notebook
The Scientist Staff | Jul 5, 1998 | 7 min read
PHANTOM PAIN GUT-WRENCHING STORY PACEMAKER IN THE BRAIN THE SCOOP ON DINO DINING SUMATRAN TIGER, A DISTINCT SPECIES FUNGUS AMONG US HONORABLE QUARTET FROM GM PAIN EXPLAINED: Washington University's Min Zhuo found that a region of the brain in rats could activate neurons in the spinal cord, possibly causing feelings of pain without any external stimulation. PHANTOM PAIN Results from a Washington University study bring up new questions about your high-school gym teacher's old proclamations tha
Increasing Number of iPS Cell Therapies Tested in Clinical Trials
Katarina Zimmer | Nov 28, 2018 | 6 min read
Since their discovery in 2006, induced pluripotent stem cells have been poised to reprogram regenerative medicine. Twelve years on, here’s how far they’ve come.
Gene Mapping Gives Rise To Drugs That Rebuild Tissue
Steve Bunk | Apr 26, 1998 | 8 min read
The logical outcome of gene mapping is nigh. Biotechnology companies are using genetic information to design new drugs that may go beyond merely slowing or stopping a disease process to inducing the regeneration or repair of damaged tissue. Looking past the conventional drug targets of enzymes and gene-coupled receptors, researchers are seeking out molecules in the pathways along which biochemical signals are transferred. In some cases, their work has led to compounds--now in clinical trials or
John Gearhart
Ricki Lewis | Dec 8, 2002 | 4 min read
File photo It is a sobering time for US stem cell researchers. Just days after a national election set the stage for the possible criminalization of embryonic stem cell research, a popular television program portrayed such cells incubating in patients in coma, ready to be used to treat a wealthy man's Parkinson disease. A video presented at the American Society for Human Genetics annual meeting in Baltimore a month earlier, however, told a very different story--this one real. The video showed

Run a Search

ADVERTISEMENT